These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 25196641

  • 1. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Jiang F, Wang X, Liu Q, Shen J, Li Z, Li Y, Zhang J.
    Toxicol Lett; 2014 Nov 18; 231(1):55-61. PubMed ID: 25196641
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
    Li Y, Jiang F, Liu Q, Shen J, Wang X, Li Z, Zhang J, Lu X.
    Toxicol Sci; 2015 Jan 18; 143(1):156-64. PubMed ID: 25304214
    [Abstract] [Full Text] [Related]

  • 3. Arsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491.
    Wang X, Jiang F, Mu J, Ye X, Si L, Ning S, Li Z, Li Y.
    Toxicol Lett; 2014 Jun 05; 227(2):75-83. PubMed ID: 24680928
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer.
    Ji H, Li Y, Jiang F, Wang X, Zhang J, Shen J, Yang X.
    Cancer Sci; 2014 Dec 05; 105(12):1541-9. PubMed ID: 25283513
    [Abstract] [Full Text] [Related]

  • 5. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    Liu ZM, Tseng JT, Hong DY, Huang HS.
    Biochem J; 2011 Sep 01; 438(2):349-58. PubMed ID: 21649584
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
    Shih TC, Tien YJ, Wen CJ, Yeh TS, Yu MC, Huang CH, Lee YS, Yen TC, Hsieh SY.
    J Hepatol; 2012 Sep 01; 57(3):584-91. PubMed ID: 22613005
    [Abstract] [Full Text] [Related]

  • 7. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
    Zhang Z, Zhang Y, Sun XX, Ma X, Chen ZN.
    Mol Cancer; 2015 Jan 21; 14():5. PubMed ID: 25608619
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide.
    Cui L, Gao B, Cao Z, Chen X, Zhang S, Zhang W.
    Mol Med Rep; 2016 Mar 21; 13(3):2032-8. PubMed ID: 26781180
    [Abstract] [Full Text] [Related]

  • 9. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
    Chen G, Wang K, Yang BY, Tang B, Chen JX, Hua ZC.
    Int J Oncol; 2012 Jan 21; 40(1):139-47. PubMed ID: 21947421
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma.
    Zhang T, Liu W, Zeng XC, Jiang N, Fu BS, Guo Y, Yi HM, Li H, Zhang Q, Chen WJ, Chen GH.
    Biomed Pharmacother; 2016 Dec 21; 84():583-591. PubMed ID: 27694002
    [Abstract] [Full Text] [Related]

  • 11. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Zhu C, Zhou R, Zhou Q, Chang Y, Jiang M.
    Life Sci; 2016 Dec 01; 166():34-40. PubMed ID: 27717846
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.
    Yang X, Zhang XF, Lu X, Jia HL, Liang L, Dong QZ, Ye QH, Qin LX.
    Hepatology; 2014 May 01; 59(5):1874-85. PubMed ID: 24259426
    [Abstract] [Full Text] [Related]

  • 13. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
    Song R, Song H, Liang Y, Yin D, Zhang H, Zheng T, Wang J, Lu Z, Song X, Pei T, Qin Y, Li Y, Xie C, Sun B, Shi H, Li S, Meng X, Yang G, Pan S, Zhu J, Qi S, Jiang H, Zhang Z, Liu L.
    Hepatology; 2014 Nov 01; 60(5):1659-73. PubMed ID: 25042864
    [Abstract] [Full Text] [Related]

  • 14. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
    Qian F, Hu Q, Tian Y, Wu J, Li D, Tao M, Qin L, Shen B, Xie Y.
    Int J Biol Sci; 2019 Nov 01; 15(2):369-385. PubMed ID: 30745827
    [Abstract] [Full Text] [Related]

  • 15. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP, Wu WK, Kang W, Lee YY, Wu F, Yu Z, Xiong L, Chan AW, Tong JH, Yang W, Li MS, Lau SS, Li X, Lee SD, Yang Y, Lai PB, Yu DY, Xu G, Lo KW, Chan MT, Wang H, Lee TL, Yu J, Wong N, Yip KY, To KF, Cheng AS.
    J Pathol; 2016 Apr 01; 238(5):651-64. PubMed ID: 26800240
    [Abstract] [Full Text] [Related]

  • 16. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y, Matsuzaki K, Tahashi Y, Furukawa F, Mori S, Yamagata H, Yoshida K, Matsushita M, Nishizawa M, Fujisawa J, Inoue K.
    Oncogene; 2003 Apr 17; 22(15):2309-21. PubMed ID: 12700666
    [Abstract] [Full Text] [Related]

  • 17. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
    Zhao L, Zhang Y.
    Biochem Biophys Res Commun; 2015 Feb 13; 457(3):370-7. PubMed ID: 25580008
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation.
    Mazzocca A, Fransvea E, Lavezzari G, Antonaci S, Giannelli G.
    Hepatology; 2009 Oct 13; 50(4):1140-51. PubMed ID: 19711426
    [Abstract] [Full Text] [Related]

  • 19. miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling.
    Yan XC, Cao J, Liang L, Wang L, Gao F, Yang ZY, Duan JL, Chang TF, Deng SM, Liu Y, Dou GR, Zhang J, Zheng QJ, Zhang P, Han H.
    J Am Heart Assoc; 2016 Feb 08; 5(2):. PubMed ID: 26857067
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.